Your browser doesn't support javascript.
loading
Cognitive domains affected post-COVID-19; a systematic review and meta-analysis.
Fanshawe, Jack B; Sargent, Brendan F; Badenoch, James B; Saini, Aman; Watson, Cameron J; Pokrovskaya, Aleksandra; Aniwattanapong, Daruj; Conti, Isabella; Nye, Charles; Burchill, Ella; Hussain, Zain U; Said, Khanafi; Kuhoga, Elinda; Tharmaratnam, Kukatharmini; Pendered, Sophie; Mbwele, Bernard; Taquet, Maxime; Wood, Greta K; Rogers, Jonathan P; Hampshire, Adam; Carson, Alan; David, Anthony S; Michael, Benedict D; Nicholson, Timothy R; Paddick, Stella-Maria; Leek, Charles E.
Afiliação
  • Fanshawe JB; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Sargent BF; Oxford Health NHS Foundation Trust, Oxford, UK.
  • Badenoch JB; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Saini A; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Watson CJ; Barts Health NHS Trust, London, UK.
  • Pokrovskaya A; Preventive Neurology Unit, Queen Mary University of London, London, UK.
  • Aniwattanapong D; School of Life and Medical Sciences, University College London, London, UK.
  • Conti I; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Nye C; South London and Maudsley NHS Foundation Trust, London, UK.
  • Burchill E; Department of Brain Sciences, Imperial College London, London, UK.
  • Hussain ZU; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Said K; Department of Psychiatry, King Chulalongkorn Memorial Hospital, Bangkok, Thailand.
  • Kuhoga E; Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Tharmaratnam K; Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK.
  • Pendered S; Division of Psychiatry, University College London, London, UK.
  • Mbwele B; NHS Greater Glasgow and Clyde, Glasgow, UK.
  • Taquet M; Edinburgh Medical School, University of Edinburgh, Edinburgh, UK.
  • Wood GK; Mbeya College of Health and Allied Sciences, University of Dar es Salaam, Mbeya, Tanzania.
  • Rogers JP; Mbeya College of Health and Allied Sciences, University of Dar es Salaam, Mbeya, Tanzania.
  • Hampshire A; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Carson A; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • David AS; Mbeya College of Health and Allied Sciences, University of Dar es Salaam, Mbeya, Tanzania.
  • Michael BD; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Nicholson TR; Oxford Health NHS Foundation Trust, Oxford, UK.
  • Paddick SM; Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK.
  • Leek CE; Division of Psychiatry, University College London, London, UK.
Eur J Neurol ; : e16181, 2024 Feb 20.
Article em En | MEDLINE | ID: mdl-38375608
ABSTRACT
BACKGROUND AND

PURPOSE:

This review aims to characterize the pattern of post-COVID-19 cognitive impairment, allowing better prediction of impact on daily function to inform clinical management and rehabilitation.

METHODS:

A systematic review and meta-analysis of neurocognitive sequelae following COVID-19 was conducted, following PRISMA-S guidelines. Studies were included if they reported domain-specific cognitive assessment in patients with COVID-19 at >4 weeks post-infection. Studies were deemed high-quality if they had >40 participants, utilized healthy controls, had low attrition rates and mitigated for confounders.

RESULTS:

Five of the seven primary Diagnostic and Statistical Manual of Mental Disorders (DSM-5) cognitive domains were assessed by enough high-quality studies to facilitate meta-analysis. Medium effect sizes indicating impairment in patients post-COVID-19 versus controls were seen across executive function (standardised mean difference (SMD) -0.45), learning and memory (SMD -0.55), complex attention (SMD -0.54) and language (SMD -0.54), with perceptual motor function appearing to be impacted to a greater degree (SMD -0.70). A narrative synthesis of the 56 low-quality studies also suggested no obvious pattern of impairment.

CONCLUSIONS:

This review found moderate impairments across multiple domains of cognition in patients post-COVID-19, with no specific pattern. The reported literature was significantly heterogeneous, with a wide variety of cognitive tasks, small sample sizes and disparate initial disease severities limiting interpretability. The finding of consistent impairment across a range of cognitive tasks suggests broad, as opposed to domain-specific, brain dysfunction. Future studies should utilize a harmonized test battery to facilitate inter-study comparisons, whilst also accounting for the interactions between COVID-19, neurological sequelae and mental health, the interplay between which might explain cognitive impairment.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article